Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(OSTEOACTIVIN). Showing records 1 – 5 of 5 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Khol, Matthew Philip. The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis.

Degree: MS, Integrated Pharmaceutical Medicine, 2014, NEOMED Integrated Pharmaceutical Medicine

 ABSTRACTIntroduction: Healthy bone constantly remodels, in balance between osteoclast bone resorption and osteoblast bone formation. Osteoclasts differentiate in vitro from osteoclast progenitor cells in the… (more)

Subjects/Keywords: Biology, Cell; Recombinant; Osteoactivin; Murine; Osteoclastogenesis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khol, M. P. (2014). The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis. (Masters Thesis). NEOMED Integrated Pharmaceutical Medicine. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380

Chicago Manual of Style (16th Edition):

Khol, Matthew Philip. “The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis.” 2014. Masters Thesis, NEOMED Integrated Pharmaceutical Medicine. Accessed September 24, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380.

MLA Handbook (7th Edition):

Khol, Matthew Philip. “The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis.” 2014. Web. 24 Sep 2020.

Vancouver:

Khol MP. The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis. [Internet] [Masters thesis]. NEOMED Integrated Pharmaceutical Medicine; 2014. [cited 2020 Sep 24]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380.

Council of Science Editors:

Khol MP. The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis. [Masters Thesis]. NEOMED Integrated Pharmaceutical Medicine; 2014. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380


Temple University

2. Belcher, Joyce Yvonne. Bone Cell Autonomous Effects of Osteoactivin In Vivo.

Degree: PhD, 2012, Temple University

Cell Biology

Osteoactivin (OA) is a type I transmembrane glycoprotein initially identified in bone in 2002. The protein is synthesized, processed and heavily glycosylated by… (more)

Subjects/Keywords: Cellular biology; Animal Model; Gpnmb; Osteoactivin; Osteoblasts; Osteoclasts; Osteopetrosis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Belcher, J. Y. (2012). Bone Cell Autonomous Effects of Osteoactivin In Vivo. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,183061

Chicago Manual of Style (16th Edition):

Belcher, Joyce Yvonne. “Bone Cell Autonomous Effects of Osteoactivin In Vivo.” 2012. Doctoral Dissertation, Temple University. Accessed September 24, 2020. http://digital.library.temple.edu/u?/p245801coll10,183061.

MLA Handbook (7th Edition):

Belcher, Joyce Yvonne. “Bone Cell Autonomous Effects of Osteoactivin In Vivo.” 2012. Web. 24 Sep 2020.

Vancouver:

Belcher JY. Bone Cell Autonomous Effects of Osteoactivin In Vivo. [Internet] [Doctoral dissertation]. Temple University; 2012. [cited 2020 Sep 24]. Available from: http://digital.library.temple.edu/u?/p245801coll10,183061.

Council of Science Editors:

Belcher JY. Bone Cell Autonomous Effects of Osteoactivin In Vivo. [Doctoral Dissertation]. Temple University; 2012. Available from: http://digital.library.temple.edu/u?/p245801coll10,183061


Temple University

3. Singh, Maneet. TRANSCRIPTIONAL REGULATION OF OSTEOACTIVIN EXPRESSION BY BMP-2 IN OSTEOBLASTS.

Degree: PhD, 2011, Temple University

Cell Biology

Osteoactivin (OA) is a glycoprotein required for the differentiation of osteoblasts. In osteoblasts, Bone Morphogenetic Protein-2 (BMP-2) activated Smad1 signaling enhances OA expression.… (more)

Subjects/Keywords: Cellular Biology; Molecular Biology; Biology; HOMEDOMAIN PROTEIN; OSTEOACTIVIN; OSTEOBLAST DIFFERENTIATION; RUNX2; SMAD1 AND SMAD4; TRANSCRIPTIONAL REGULATION

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Singh, M. (2011). TRANSCRIPTIONAL REGULATION OF OSTEOACTIVIN EXPRESSION BY BMP-2 IN OSTEOBLASTS. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,135232

Chicago Manual of Style (16th Edition):

Singh, Maneet. “TRANSCRIPTIONAL REGULATION OF OSTEOACTIVIN EXPRESSION BY BMP-2 IN OSTEOBLASTS.” 2011. Doctoral Dissertation, Temple University. Accessed September 24, 2020. http://digital.library.temple.edu/u?/p245801coll10,135232.

MLA Handbook (7th Edition):

Singh, Maneet. “TRANSCRIPTIONAL REGULATION OF OSTEOACTIVIN EXPRESSION BY BMP-2 IN OSTEOBLASTS.” 2011. Web. 24 Sep 2020.

Vancouver:

Singh M. TRANSCRIPTIONAL REGULATION OF OSTEOACTIVIN EXPRESSION BY BMP-2 IN OSTEOBLASTS. [Internet] [Doctoral dissertation]. Temple University; 2011. [cited 2020 Sep 24]. Available from: http://digital.library.temple.edu/u?/p245801coll10,135232.

Council of Science Editors:

Singh M. TRANSCRIPTIONAL REGULATION OF OSTEOACTIVIN EXPRESSION BY BMP-2 IN OSTEOBLASTS. [Doctoral Dissertation]. Temple University; 2011. Available from: http://digital.library.temple.edu/u?/p245801coll10,135232


University of Oulu

4. Pohjolainen, V. (Virva). Characterization of non-collagenous extracellular matrix proteins in cardiac and aortic valve remodelling.

Degree: 2012, University of Oulu

Abstract Heart failure (HF) and aortic valve stenosis (AS) are complex disorders affected by functional alterations and actively regulated remodelling of the heart and the… (more)

Subjects/Keywords: aortic valve stenosis; bone morphogenetic protein; bone sialoprotein; cardiac remodelling; matrix Gla protein; osteoactivin; osteopontin; osteoprotegerin; periostin; pleiotrophin; thrombospondin; aorttastenoosi; soluväliaineen proteiinit; sydämen uudelleenmuovautuminen; sydämen vajaatoiminta

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pohjolainen, V. (. (2012). Characterization of non-collagenous extracellular matrix proteins in cardiac and aortic valve remodelling. (Doctoral Dissertation). University of Oulu. Retrieved from http://urn.fi/urn:isbn:9789514299025

Chicago Manual of Style (16th Edition):

Pohjolainen, V (Virva). “Characterization of non-collagenous extracellular matrix proteins in cardiac and aortic valve remodelling.” 2012. Doctoral Dissertation, University of Oulu. Accessed September 24, 2020. http://urn.fi/urn:isbn:9789514299025.

MLA Handbook (7th Edition):

Pohjolainen, V (Virva). “Characterization of non-collagenous extracellular matrix proteins in cardiac and aortic valve remodelling.” 2012. Web. 24 Sep 2020.

Vancouver:

Pohjolainen V(. Characterization of non-collagenous extracellular matrix proteins in cardiac and aortic valve remodelling. [Internet] [Doctoral dissertation]. University of Oulu; 2012. [cited 2020 Sep 24]. Available from: http://urn.fi/urn:isbn:9789514299025.

Council of Science Editors:

Pohjolainen V(. Characterization of non-collagenous extracellular matrix proteins in cardiac and aortic valve remodelling. [Doctoral Dissertation]. University of Oulu; 2012. Available from: http://urn.fi/urn:isbn:9789514299025

5. Stinnett, Hilary M. OSTEOACTIVIN IN SKELETON: CHARACTERIZATION OF OSTEOACTIVIN KNOCKOUT MICE & THERAPEUTIC IMPLICATIONS.

Degree: PhD, College of Arts and Sciences / School of Biomedical Sciences, 2015, Kent State University

 Osteoporosis impacts 55% of the population aged 50 and older, with post-menopausal, thin women of Caucasian descent at the highest risk for developing this disease.… (more)

Subjects/Keywords: Biology; Pharmacology; Cellular Biology; osteoactivin, osteoblast, osteoclast, gpnmb, osteoporosis, knockout mouse model, surgical model, ovariectomy

…19 Figure 2.5. Osteoactivin Sequence with Highlighted Peptide Sequence… …Figure 4.1. Osteoactivin ELISA used for Genotyping Mice… …T-Cells OA Osteoactivin OA +/+ Osteoactivin Wildtype Littermates OA -/- Osteoactivin… …Global Knockout OA-D Osteoactivin-D Peptide OC Osteocalcin OPG Osteoprotegrin xiii PLCγ… …Srinivasan Vijayaraghavan. Hilary Stinnett April 6, 2015 Kent, Ohio xvi ABSTRACT OSTEOACTIVIN… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stinnett, H. M. (2015). OSTEOACTIVIN IN SKELETON: CHARACTERIZATION OF OSTEOACTIVIN KNOCKOUT MICE & THERAPEUTIC IMPLICATIONS. (Doctoral Dissertation). Kent State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=kent1428859108

Chicago Manual of Style (16th Edition):

Stinnett, Hilary M. “OSTEOACTIVIN IN SKELETON: CHARACTERIZATION OF OSTEOACTIVIN KNOCKOUT MICE & THERAPEUTIC IMPLICATIONS.” 2015. Doctoral Dissertation, Kent State University. Accessed September 24, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=kent1428859108.

MLA Handbook (7th Edition):

Stinnett, Hilary M. “OSTEOACTIVIN IN SKELETON: CHARACTERIZATION OF OSTEOACTIVIN KNOCKOUT MICE & THERAPEUTIC IMPLICATIONS.” 2015. Web. 24 Sep 2020.

Vancouver:

Stinnett HM. OSTEOACTIVIN IN SKELETON: CHARACTERIZATION OF OSTEOACTIVIN KNOCKOUT MICE & THERAPEUTIC IMPLICATIONS. [Internet] [Doctoral dissertation]. Kent State University; 2015. [cited 2020 Sep 24]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=kent1428859108.

Council of Science Editors:

Stinnett HM. OSTEOACTIVIN IN SKELETON: CHARACTERIZATION OF OSTEOACTIVIN KNOCKOUT MICE & THERAPEUTIC IMPLICATIONS. [Doctoral Dissertation]. Kent State University; 2015. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=kent1428859108

.